Nano-X Imaging (NASDAQ:NNOX – Get Free Report) will likely be releasing its Q3 2026 results before the market opens on Thursday, November 19th. Analysts expect Nano-X Imaging to announce earnings of ($0.1467) per share and revenue of $5.33 million for the quarter. Individuals may review the information on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Wednesday, November 25, 2026 at 8:30 AM ET.
Nano-X Imaging (NASDAQ:NNOX – Get Free Report) last released its earnings results on Wednesday, September 9th. The company reported ($0.79) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.63). Nano-X Imaging had a negative return on equity of 116.93% and a negative net margin of 926.05%. The firm had revenue of $4.16 million during the quarter, compared to analysts’ expectations of $5.38 million. On average, analysts expect Nano-X Imaging to post ($1.23) EPS for the current fiscal year and ($0.41) EPS for the next fiscal year.
Nano-X Imaging Trading Down 0.6%
NASDAQ NNOX opened at $0.32 on Tuesday. Nano-X Imaging has a 12 month low of $0.21 and a 12 month high of $4.71. The stock has a market cap of $25.22 million, a price-to-earnings ratio of -0.15 and a beta of 1.38. The company’s 50 day moving average is $0.52 and its two-hundred day moving average is $1.46.
Analysts Set New Price Targets
A number of equities analysts have weighed in on NNOX shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nano-X Imaging in a research report on Friday, October 2nd. Cantor Fitzgerald restated an “overweight” rating and set a $5.00 price objective on shares of Nano-X Imaging in a research report on Monday, August 17th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $4.33.
View Our Latest Stock Report on Nano-X Imaging
Insider Transactions at Nano-X Imaging
In related news, Director Dan S. Suesskind acquired 60,000 shares of Nano-X Imaging stock in a transaction dated Monday, September 14th. The shares were purchased at an average price of $0.76 per share, for a total transaction of $45,600.00. Following the completion of the transaction, the director directly owned 110,000 shares in the company, valued at approximately $83,600. This represents a 120.00% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Over the last ninety days, insiders have purchased 105,000 shares of company stock worth $71,550.
About Nano-X Imaging
Nano-X Imaging Ltd. is an Israeli medical technology company developing digital X-ray imaging systems and related services. Its Nanox.ARC system is designed to produce medical images using the company’s digital X-ray technology, with the goal of expanding access to diagnostic imaging. The company’s broader offering includes Nanox.CLOUD, a cloud-based platform intended to connect imaging systems with image-management and diagnostic services, and Nanox.AI, which develops artificial-intelligence tools for analyzing medical images.
See Also
- Five stocks we like better than Nano-X Imaging
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
